痴呆症的正式护理成本:使用瑞典登记数据进行纵向研究
Jennifer Zilling1, Ulf-G Gerdtham1,2,3, Johan Jarl1
1Health Economics Unit, Department of Clinical Sciences (Malmö), Forum Medicum, Lund University, Sölvegatan 19, 223 62, Lund, Sweden.
概括
痴呆症的经济负担很大,诊断后过度的正式护理成本显著增加. 孤独生活预测成本更高,强调需要全面的痴呆症护理策略.
科学领域:
- 老年学是一门学科.
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 痴呆症诊断显著影响医疗保健和社会护理费用.
- 社会人口结构因素影响痴呆症护理的经济负担.
研究的目的:
- 调查与痴呆相关的过度成本.
- 分析社会人口统计学群体之间的成本差异.
主要方法:
- 使用了瑞典注册数据 (2013-2016).
- 将被诊断患有痴呆症的个人 (n=15,339) 与人口对照进行了比较.
- 采用纵向回归分析来确定过度的正式护理成本.
主要成果:
- 患有痴呆症的个人在整个研究期间的正式护理费用高于对照组.
- 超额费用从诊断前的3400欧元升至诊断后的49,700欧元.
- 机构护理推动了成本;单身生活是高过度成本的关键预测因素.
结论:
- 痴呆症患者的正式护理费用是相当大的.
- 在瑞典,痴呆症的经济影响比以前估计的要大.
- 这些发现强调了需要具有成本效益的痴呆症护理干预措施.
相关概念视频
Dementia
109
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
109
Documentation in Long-Term and Home Healthcare Setting
876
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
876
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Continuing Care
1.4K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.4K
Restorative Care
1.9K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
1.9K


